Prognostic implications of HER2NEU-low in metastatic breast cancer.
Zachary NeubauerShaakir HasanRobert H PressArpit M ChhabraJana FoxRichard BakstCharles B Simone IiJ Isabelle ChoiPublished in: Cancer medicine (2024)
In the largest such analysis performed to date, our study demonstrates a small but statistically significant association with improved survival for HER2-low tumors compared to HER2-negative tumors in MBC.
Keyphrases